Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Brigham and Women's Hospital
Study ID
NCT01258231
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
20 Years - 90 Years
Healthy Volunteers
Not accepted

Study Details

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

Key Dates

Start date
Aug 31, 2000
Status verified
Aug 2024
Primary completion
Aug 31, 2030
Completion
Aug 31, 2030

Study Design

Enrollment
4,000 participants (estimated)

Arms

  • Arm: Cardiac surgery
    Adult patients undergoing cardiac surgery

Primary Outcome Measure

Mortality (i.e. number of participants who are deceased during postoperative day 0 up to year 5) [ Time Frame: Day of procedure to year 5 ]

Locations (3)

FacilityCityStateZIPSite coordinators
Brigham and Women's HospitalBostonMassachusetts02115-
UT Southwestern Medical CenterDallasTexas75390-9068
Amanda A Fox, MD
[email protected]
214-648-8018
Amanda A Fox, MD (PRINCIPAL_INVESTIGATOR)
Department Texas Heart Institute at St. Luke's Episcopal HospitalHoustonTexas77225-

Find similar trials in Boston, MA

By condition
Atrial fibrillationHeart failure
By specialty
CardiologyHeart disease
By research site
Brigham and Women's Hospital· Boston, MAUT Southwestern Medical Center· Dallas, TXDepartment Texas Heart Institute at St. Luke's Episcopal Hospital· Houston, TX

Related Studies